Healthcare News

Browse the latest Healthcare news, including Healthcare Providers, Medical Equipment, Medical Supplies and Services, Biotechnology and Pharmaceuticals, and Cannabis industries. Use the menu or navigation tiles to get to specific industries within each sector.

October 29, 2025 17:05 ET | Source: Vaxil Bio Ltd.

Vaxil Announces Non-Brokered Private Placement

Not for distribution by US newswire or in United States NESS-ZIONA, ISRAEL, Oct. 29, 2025 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), is pleased to announce...
October 29, 2025 17:00 ET | Source: Cytek Biosciences, Inc.

Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry

Cytek has launched a two-part research support initiative to make cell analysis more accessible.
October 29, 2025 16:15 ET | Source: Wave Life Sciences USA, Inc.

Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day

Dose-dependent mean reductions of Activin E of up to 85% one month post single dose of WVE-007 in INLIGHT clinical trial, exceeding levels that led to weight loss in preclinical models; WVE-007 is...
October 29, 2025 16:05 ET | Source: Spyre Therapeutics, Inc.

Spyre Therapeutics to Participate in Upcoming November Investor Conferences

WALTHAM, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to...
October 29, 2025 16:05 ET | Source: Amneal Pharmaceuticals LLC

Amneal Receives U.S. FDA Tentative Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol

BRIDGEWATER, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has tentatively...
October 29, 2025 16:05 ET | Source: Glucotrack, Inc.

Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team

RUTHERFORD, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc.(“Glucotrack”, or the “Company”) (Nasdaq: GCTK), a medical device company focused on the design, development, and...
October 29, 2025 16:05 ET | Source: Seer, Inc.

Seer to Participate in Upcoming November Investor Conferences

REDWOOD CITY, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced company management will be...
October 29, 2025 16:05 ET | Source: Revolution Medicines, Inc.

Revolution Medicines to Report Financial Results for Third Quarter 2025 After Market Close on November 5, 2025

REDWOOD CITY, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted...
October 29, 2025 16:01 ET | Source: Tectonic Therapeutic

Tectonic Therapeutic Announces Positive Topline Data from Phase 1b Part B Clinical Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFrEF

TX45 improved both left heart function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with reduced Ejection Fraction (“PH‑HFrEF”)TX45 was well tolerated in...
October 29, 2025 16:01 ET | Source: BridgeBio Pharma, Inc.

BridgeBio Reports Third Quarter 2025 Financial Results and Business Updates

-$120.7 million in total third quarter revenue, comprised of $108.1 million of U.S. Attruby® net product revenue, $4.3 million from royalty revenue, and $8.3 million in license and services revenue-As...